Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Consolidated Net Income (2018 - 2025)

TransMedics has reported Consolidated Net Income over the past 8 years, most recently at $18.6 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $18.6 million for Q4 2025, up 167.08% from a year ago — trailing twelve months through Dec 2025 was $103.5 million (up 190.92% YoY), and the annual figure for FY2025 was $1.1 million, down 96.87%.
  • Consolidated Net Income for Q4 2025 was $18.6 million at TransMedics, down from $24.3 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for TMDX hit a ceiling of $34.9 million in Q2 2025 and a floor of -$25.4 million in Q3 2023.
  • Median Consolidated Net Income over the past 5 years was $681500.0 (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Consolidated Net Income: tumbled 242.34% in 2023 and later soared 1318.18% in 2024.
  • TransMedics' Consolidated Net Income stood at $31.7 million in 2021, then tumbled by 122.02% to -$7.0 million in 2022, then surged by 133.91% to $2.4 million in 2023, then surged by 194.29% to $7.0 million in 2024, then skyrocketed by 167.08% to $18.6 million in 2025.
  • The last three reported values for Consolidated Net Income were $18.6 million (Q4 2025), $24.3 million (Q3 2025), and $34.9 million (Q2 2025) per Business Quant data.